Alprostadil liposomal - Yipinhong PharmaceuticalAlternative Names: Alprostadil liposomes for injection
Latest Information Update: 22 Sep 2016
At a glance
- Originator Yipinhong Pharmaceutical
- Class Erectile dysfunction therapies; Monounsaturated fatty acids; Muscle relaxants; Peripheral vasodilators; Prostaglandins; Small molecules
- Mechanism of Action Prostaglandin E1 agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase I Arteriosclerosis obliterans
Most Recent Events
- 13 Sep 2016 Yipinhong Pharmaceutical plans a phase II trial for Arteriosclerosis obliterans in China (NCT02877173)